23
https://pubmed.ncbi.nlm.nih.gov/38113337
LSD1 inhibition in macrophages modulates the balance between inflammatory and antiviral responses to coronaviruses, suggesting a potential repurposing of LSD1 inhibitors for COVID-19 treatment.